Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)
- PMID: 38590940
- PMCID: PMC10999471
- DOI: 10.1016/j.lanepe.2024.100892
Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)
Erratum in
-
Corrigendum to "Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)" [The Lancet Regional Health - Europe 40 (2024) 100892].Lancet Reg Health Eur. 2024 Jun 24;42:100974. doi: 10.1016/j.lanepe.2024.100974. eCollection 2024 Jul. Lancet Reg Health Eur. 2024. PMID: 39050231 Free PMC article.
Abstract
Congenital cytomegalovirus (cCMV) infection carries a significant burden with a 0.64% global prevalence and a 17-20% chance of serious long-term effects in children. Since the last guidelines, our understanding, particularly regarding primary maternal infections, has improved. A cCMV guidelines group was convened under the patronage of the European Society of Clinical Virology in April 2023 to refine these insights. The quality and validity of selected studies were assessed for potential biases and the GRADE framework was employed to evaluate quality of evidence across key domains. The resulting recommendations address managing cCMV, spanning prevention to postnatal care. Emphasizing early and accurate maternal diagnosis through serological tests enhances risk management and prevention strategies, including using valaciclovir to prevent vertical transmission. The guidelines also strive to refine personalized postnatal care based on risk assessments, ensuring targeted interventions for affected families.
Keywords: Congenital cytomegalovirus infection; Guidelines; Neonatal; Postnatal; Prenatal.
© 2024 The Author(s).
Conflict of interest statement
MLV reports receiving support for attending meetings by BioMérieux and Altona outside the submitted work. MLV reports payment made to her institution for presentation/lecture by Diasorin, Abbott Molecular and Roche Diagnostic outside the submitted work. DBG received Grant from the Spanish Ministry of Science and Innovation. ISCIII and Fondos FEDER (EU) outside the submitted work and received Honoraria for lectures from the Medscape, outside the submitted work. JF received honoraria for poster presentation by Abbott GmbH, outside the submitted work. CJ received consulting fees from Moderna, outside the submitted work; Participated on a Data Safety Monitoring Board or Advisory Board of Moderna, outside the submitted work; Is Co-director of the European Congenital CMV Initiative; Her institution received payment for clinical trials by Moderna, outside the submitted work. HL participated on advisory board for the Study of Zidovudine in children with Aicadri-Goutiere Syndrome, outside the submitted work and she is Trustee of European Society For Paediatric Infectious Diseases (ESPID). VP institution received honoraria for lectures from MSD and Pfizer, outside the submitted work and received support for attending a meeting (ESPID 2023) from Pfizer. PV is president and board-member of the European Congenital CMV Initiative. AV is participating in the Advisory Council European Society of Virology. The rest author of the authors declare no conflict of interest.
Similar articles
-
Corrigendum to "Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)" [The Lancet Regional Health - Europe 40 (2024) 100892].Lancet Reg Health Eur. 2024 Jun 24;42:100974. doi: 10.1016/j.lanepe.2024.100974. eCollection 2024 Jul. Lancet Reg Health Eur. 2024. PMID: 39050231 Free PMC article.
-
Leaning towards Cytomegalovirus serological screening in pregnancy to prevent congenital infection: a cost-effectiveness perspective.BJOG. 2022 Jan;129(2):301-312. doi: 10.1111/1471-0528.16966. Epub 2021 Nov 9. BJOG. 2022. PMID: 34651405
-
Cytomegalovirus infection during pregnancy: state of the science.Am J Obstet Gynecol. 2020 Sep;223(3):330-349. doi: 10.1016/j.ajog.2020.02.018. Epub 2020 Feb 24. Am J Obstet Gynecol. 2020. PMID: 32105678 Review.
-
A Qualitative Assessment of Clinical Practice Guidelines and Patterns for Congenital Cytomegalovirus in the United States.Int J Neonatal Screen. 2023 Jun 30;9(3):37. doi: 10.3390/ijns9030037. Int J Neonatal Screen. 2023. PMID: 37489490 Free PMC article.
-
Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts.Front Pediatr. 2020 Jan 31;8:13. doi: 10.3389/fped.2020.00013. eCollection 2020. Front Pediatr. 2020. PMID: 32083040 Free PMC article. Review.
Cited by
-
Polymicrogyria in infants with symptomatic congenital cytomegalovirus at birth is associated with epilepsy: A retrospective, descriptive cohort study.Dev Med Child Neurol. 2025 Aug;67(8):1026-1033. doi: 10.1111/dmcn.16250. Epub 2025 Jan 27. Dev Med Child Neurol. 2025. PMID: 39869483 Free PMC article.
-
Clinical Manifestations of Non-Congenital CMV Infection in Infants and Immunocompetent Children: Review of Cases from the Past Decade.Microorganisms. 2025 Mar 28;13(4):772. doi: 10.3390/microorganisms13040772. Microorganisms. 2025. PMID: 40284610 Free PMC article. Review.
-
Cochlear Implant in Children with Congenital CMV Infection: Long-Term Results from an Italian Multicentric Study.Children (Basel). 2025 Jul 10;12(7):908. doi: 10.3390/children12070908. Children (Basel). 2025. PMID: 40723101 Free PMC article.
-
Congenital Cytomegalovirus Severity Definitions and Treatment Decisions around the World: A Systematic Scoping Review of the Literature.J Clin Med. 2024 Oct 8;13(19):5997. doi: 10.3390/jcm13195997. J Clin Med. 2024. PMID: 39408057 Free PMC article.
-
Congenital cytomegalovirus screening in neonates born after 35 weeks gestation-is targeted screening beneficial?Front Pediatr. 2025 Feb 13;13:1510612. doi: 10.3389/fped.2025.1510612. eCollection 2025. Front Pediatr. 2025. PMID: 40017708 Free PMC article.
References
-
- Kenneson A., Cannon M.J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–276. - PubMed
-
- Dollard S.C., Grosse S.D., Ross D.S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–363. - PubMed
-
- Rawlinson W.D., Boppana S.B., Fowler K.B., et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17:e177–e188. - PubMed
-
- Luck S.E., Wieringa J.W., Blázquez-Gamero D., et al. Congenital cytomegalovirus: a European expert consensus Statement on diagnosis and management. Pediatr Infect Dis J. 2017;36:1205–1213. - PubMed
-
- Shahar-Nissan K., Pardo J., Peled O., et al. Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial. Lancet. 2020;396:779–785. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous